Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EO4010 |
Trade Name | |
Synonyms | EO-4010|EO 4010 |
Drug Descriptions |
EO4010 is a cancer peptide vaccine composed of bacterial-derived peptides that are homologous to tumor-associated antigens (TAA), which potentially induces an anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192811 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EO4010 | EO4010 | 0 | 1 |
EO4010 + Nivolumab | EO4010 Nivolumab | 0 | 1 |